DGAP-News: Apricus Biosciences Strengthens Vitaros(R) and Nexact(R) Patent Estate With Two New Patent Allowances
Apricus Biosciences, Inc.
25.05.2012 19:20
—————————————————————————
SAN DIEGO, 2012-05-25 19:20 CEST (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com), announced today that the Canadian Intellectual
Property Office issued a Notice of Allowance for a Canadian patent on certain
methods of manufacture for the Company–s platform NexACT(r) drug delivery
technology.
Speci
